The immune network in thyroid cancer

被引：114

作者：

Galdiero, Maria Rosaria ^{[1
]}

Varricchi, Gilda ^{[1
]}

Marone, Gianni ^{[1
,2
]}

机构：

[1] Univ Naples Federico II, Sch Med, Dept Translat Med Sci DiSMeT, Naples, Italy

[2] CNR, Inst Expt Endocrinol & Oncol Gaetano Salvatore IE, Naples, Italy

来源：

ONCOIMMUNOLOGY | 2016年 / 5卷 / 06期

关键词：

Angiogenesis; chemokines; CXCL8/IL-8; dendritic cells; lymphangiogenesis; macrophages; mast cells; neutrophils; thyroid cancer; T reg cells; TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTORS; REGULATORY T-CELLS; DENDRITIC CELLS; NK CELLS; MESENCHYMAL TRANSITION; AUTOCRINE PRODUCTION; PAPILLARY CARCINOMA; AGGRESSIVE FEATURES; CHEMOKINE CXCL10;

D O I：

10.1080/2162402X.2016.1168556

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The immune system plays critical roles in tumor prevention, but also in its initiation and progression. Tumors are subjected to immunosurveillance, but cancer cells generate an immunosuppressive microenvironment that favors their escape from immune-mediated elimination. During chronic inflammation, immune cells can contribute to the formation and progression of tumors by producing mitogenic, prosurvival, proangiogenic and lymphangiogenic factors. Thyroid cancer is the most frequent type of endocrine neoplasia and is the most rapidly increasing cancer in the US. In this review, we discuss recent findings on how different immune cells and mediators can contribute to thyroid cancer development and progression.

引用

页数：11

共 117 条

[1] Integrated Genomic Characterization of Papillary Thyroid Carcinoma [J].

Agrawal, Nishant ;

Akbani, Rehan ;

Aksoy, B. Arman ;

Ally, Adrian ;

Arachchi, Harindra ;

Asa, Sylvia L. ;

Auman, J. Todd ;

Balasundaram, Miruna ;

Balu, Saianand ;

Baylin, Stephen B. ;

Behera, Madhusmita ;

Bernard, Brady ;

Beroukhim, Rameen ;

Bishop, Justin A. ;

Black, Aaron D. ;

Bodenheimer, Tom ;

Boice, Lori ;

Bootwalla, Moiz S. ;

Bowen, Jay ;

Bowlby, Reanne ;

Bristow, Christopher A. ;

Brookens, Robin ;

Brooks, Denise ;

Bryant, Robert ;

Buda, Elizabeth ;

Butterfield, Yaron S. N. ;

Carling, Tobias ;

Carlsen, Rebecca ;

Carter, Scott L. ;

Carty, Sally E. ;

Chan, Timothy A. ;

Chen, Amy Y. ;

Cherniack, Andrew D. ;

Cheung, Dorothy ;

Chin, Lynda ;

Cho, Juok ;

Chu, Andy ;

Chuah, Eric ;

Cibulskis, Kristian ;

Ciriello, Giovanni ;

Clarke, Amanda ;

Clayman, Gary L. ;

Cope, Leslie ;

Copland, John A. ;

Covington, Kyle ;

Danilova, Ludmila ;

Davidsen, Tanja ;

Demchok, John A. ;

DiCara, Daniel ;

Dhalla, Noreen .

CELL, 2014, 159 (03) :676-690

[2]

Akdis M., 2011, JAIIERGY CLINLMMUNOL, V127, pe1

[3] Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases [J].

Akdis, Muebeccel ;

Burgler, Simone ;

Crameri, Reto ;

Eiwegger, Thomas ;

Fujita, Hiroyuki ;

Gomez, Enrique ;

Klunker, Sven ;

Meyer, Norbert ;

O'Mahony, Liam ;

Palomares, Oscar ;

Rhyner, Claudio ;

Quaked, Nadia ;

Schaffartzik, Anna ;

Van De Veen, Willem ;

Zeller, Sabine ;

Zimmermann, Maya ;

Akdis, Cezmi A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (03) :701-U317

[4] NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation [J].

Ameziane-El-Hassani, Rabii ;

Talbot, Monique ;

Dos Santos, Maria Carolina de Souza ;

Al Ghuzlan, Abir ;

Hartl, Dana ;

Bidart, Jean-Michel ;

De Deken, Xavier ;

Miot, Francoise ;

Diallo, Ibrahima ;

de Vathaire, Florent ;

Schlumberger, Martin ;

Dupuy, Corinne .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (16) :5051-5056

[5] MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro [J].

Angell, Trevor E. ;

Lechner, Melissa G. ;

Jang, Julie K. ;

LoPresti, Jonathan S. ;

Epstein, Alan L. .

CLINICAL CANCER RESEARCH, 2014, 20 (23) :6034-6044

[6] BRAFV600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration [J].

Angell, Trevor E. ;

Lechner, Melissa G. ;

Jang, Julie K. ;

Correa, Adrian J. ;

LoPresti, Jonathan S. ;

Epstein, Alan L. .

THYROID, 2014, 24 (09) :1385-1393

[7]

[Anonymous], AM J SURG

[8] Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer [J].

Antonelli, Alessandro ;

Ferrari, Silvia Martina ;

Fallahi, Poupak ;

Piaggi, Simona ;

Di Domenicantonio, Andrea ;

Galleri, David ;

Santarpia, Libero ;

Basolo, Fulvio ;

Ferrannini, Ele ;

Miccoli, Paolo .

CYTOKINE, 2012, 59 (02) :218-222

[9] Dysregulation of secretion of CXC α-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-γ agonists [J].

Antonelli, Alessandro ;

Ferrari, Silvia Martina ;

Fallahi, Poupak ;

Frascerra, Silvia ;

Piaggi, Simona ;

Gelmini, Stefania ;

Lupi, Cristiana ;

Minuto, Michele ;

Berti, Piero ;

Benvenga, Salvatore ;

Basolo, Fulvio ;

Orlando, Claudio ;

Miccoli, Paolo .

[10] The biology of innate lymphoid cells [J].

Artis, David ;

Spits, Hergen .

NATURE, 2015, 517 (7534) :293-301

← 1 2 3 4 5 6 7 8 9 10 →